CSX
27
-4
FCX
16
-11
REGN
23
-7
MU
32
-3
MCK
70
-11
INTU
41
-19
K
47
-15
MCO
46
-13
GWW
44
-7
SRE
30
-12
PPG
27
-8
EQIX
43
-9
PFG
28
-11
MCD
46
-16
ITW
18
-9
BAX
30
-8
MTB
46
-7
BK
43
-15
MAS
36
-6
CMA
33
-7
CSX
27
-4
FCX
16
-11
REGN
23
-7
MU
32
-3
MCK
70
-11
INTU
41
-19
K
47
-15
MCO
46
-13
GWW
44
-7
SRE
30
-12
PPG
27
-8
EQIX
43
-9
PFG
28
-11
MCD
46
-16
ITW
18
-9
BAX
30
-8
MTB
46
-7
BK
43
-15
MAS
36
-6
CMA
33
-7
Financhill
Back

Krystal Biotech 10K Form

Sell
48

KRYS
Krystal Biotech

Last Price:
$171.14
Seasonality Move:
20.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KRYS News And Ratings

See the #1 stock for the next 7 days that we like better than KRYS

KRYS Financial Statistics

Sales & Book Value

Annual Sales: $290.5M
Cash Flow: $52M
Price / Cash Flow: 42.68
Annual Sales: $32.87
Price / Book: 5.21

Profitability

EPS (TTM): 2.99000
Net Income (TTM): $89.2M
Gross Margin: $270.5M
Return on Equity: 10.49%
Return on Assets: 9.63%

Krystal Biotech Earnings Forecast

Key Krystal Biotech Financial Ratios

  • The Gross Profit Margin over the past 4 years for KRYS is 93.09%.
  • The Selling, General & Administrative Expenses for KRYS have been equal to 39.13% of Gross Profit Margin.
  • The Research & Development expenses have been 18.44% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of KRYS is 30.69% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

Krystal Biotech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: KRYS
CUSIP: 501147
Website: krystalbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 7.28
Quick Ratio: 6.89

Price-to-Earnings

Trailing P/E Ratio: 57.1
Forward P/E Ratio: 15.91

KRYS Technical Analysis vs Fundamental Analysis

Sell
48
Krystal Biotech (KRYS) is a Sell

Is Krystal Biotech a Buy or a Sell?

  • Krystal Biotech stock is rated a Sell
    The current Krystal Biotech [KRYS] share price is $171.30. The Score for KRYS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.